Skip to main content

Table 2 Data about pediatric population affected by MPS [4]

From: Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review

Authors

Patients

MPS

Musculoskeletal pain

Brans et al

89 adult and pediatric MPS subjects (55 of whom agreed to participate)

MPS I, MPS II, MPS III, MPS IV, MPS VI, MPS type unknown

69% of children reported joint pain, mainly hip (27,8%) and back pain (25,9%). The highest frequency of pain was observed in MPS III group (52.9%)

Hendriksz et al

Adult and pediatric MPS subjects with

Morquio A Syndrome (MPS IVA)

64% of children reported joint pain (spinal area (63%), lower extremities (100%), upper extremities (69%), and head and neck area (56%))

Vijay and Wraith

29 adult and pediatric MPS subjects

Attenuated MPSI phenotype

Progressive arthropathy (86%), fixed flexion deformity of the fingers (24%), and kyphosis, scoliosis, and/or lordosis (24%)

White and Sousa

18 pediatric MPS subjects

MPSIII

Many subjects requested orthopaedic evaluation of hip pain (hip dysplasia in 8 subjects; bilateral osteonecrosis of the femoral heads in 4 subjects)

de Ruijter et al

33 adult and pediatric MPS III subjects

MPS-3A, MPS-3B, MPS-3C

For 15 of the 33 subjects pain was indicated in one or both hips